Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of NEPTUNE
Quarter-by-quarter operating performance
Financials of NEPTUNE
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 81 | 708 | 668 | 948 | 1,052 |
| Expenses + | 81 | 695 | 647 | 924 | 1,020 |
| Operating Profit | -0 | 13 | 20 | 24 | 32 |
| OPM % | -0% | 2% | 3% | 2% | 3% |
| Other Income + | 1 | 1 | 8 | 11 | 11 |
| Interest | 0 | 1 | 0 | 0 | 2 |
| Depreciation | 0 | 0 | 0 | 1 | 1 |
| Profit before tax | 1 | 14 | 28 | 34 | 41 |
| Tax % | 26% | 25% | 26% | 26% | 25% |
| Net Profit + | 1 | 10 | 21 | 25 | 30 |
| EPS in Rs | 680.00 | 10,390.00 | 20,770.00 | 15.07 | 13.39 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of NEPTUNE
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 17 | 23 |
| Reserves | 1 | 11 | 32 | 50 | 148 |
| Borrowings + | 0 | 5 | 0 | 11 | 19 |
| Other Liabilities + | 97 | 92 | 89 | 125 | 30 |
| Total Liabilities | 98 | 108 | 121 | 203 | 219 |
| Fixed Assets + | 0 | 1 | 3 | 3 | 5 |
| CWIP | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 1 | 0 | 0 | 0 |
| Other Assets + | 97 | 106 | 118 | 199 | 214 |
| Total Assets | 98 | 108 | 121 | 203 | 219 |
Financials of NEPTUNE
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 12 | -7 | 17 | 56 | -63 |
| Cash from Investing Activity + | 0 | -1 | -4 | -9 | -91 |
| Cash from Financing Activity + | -0 | 5 | -5 | 21 | 80 |
| Net Cash Flow | 12 | -3 | 8 | 68 | -74 |
| Free Cash Flow | 12 | -8 | 15 | 55 | -65 |
| CFO/OP | -30,375% | -26% | 113% | 285% | -164% |
Financials of NEPTUNE
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 175 | 27 | 39 | 26 | 16 |
| Inventory Days | 184 | 20 | 15 | 14 | 10 |
| Days Payable | 429 | 45 | 46 | 35 | 0 |
| Cash Conversion Cycle | -70 | 2 | 8 | 6 | 25 |
| Working Capital Days | -50 | 0 | 6 | -9 | 21 |
| ROCE % | 171% | 118% | 62% | 32% |
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…